Literature DB >> 14684158

A balanced expression of two chains of heterodimer protein, the human interleukin-12, improves high-level expression of the protein in CHO cells.

Wentao Liu1, Haiming Wei, Shujuan Liang, Jian Zhang, Rui Sun, Zhigang Tian.   

Abstract

Interleukin-12 (IL-12) comprises of p40 and p35 subunits that are encoded by genes on separate chromosomes and form p70 heterodimer, a bioactive protein, and free p40, an antagonist of IL-12. Balance expression of two subunits within cells would be the key for high-level of production of bioactive IL-12. Thinking about different expression efficiencies of two genes (p40 gene with higher efficiency), we selected two expression vectors with different efficiencies and inserted genes of p40 and p35 into them separately and co-transfected them into Chinese hamster ovary (CHO) cells. The high-level expression of IL-12 was obtained when p40 cDNA was inserted into pcDNA3 (lower expression vector) and p35 cDNA was inserted into pEE14 (higher expression vector), but using pEE14 for p40 cDNA and pcDNA3 for p35 cDNA, which was opposite to the optimal design, or pEE14 or pcDNA3 for both p35 cDNA and p40 cDNA did not obtain high-level of production of p70 heterodimer, the bioactive IL-12. We also observed that using two chemical reagents in combination, as a pressure selection method or amplification for the two vectors, markedly enhanced the IL-12 production, when compared with any one selection chemical. Our results indicated that the balance expressions of two chains of hetrodimer protein, such as p40 and p35 of IL-12, would be a better choice to obtain high-level of production of the proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14684158     DOI: 10.1016/j.bbrc.2003.11.125

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Expression Enhancement in Trastuzumab Therapeutic Monoclonal Antibody Production using Genomic Amplification with Methotrexate.

Authors:  Soudabeh Akbarzadeh-Sharbaf; Bagher Yakhchali; Zarrin Minuchehr; Mohammad Ali Shokrgozar; Sirous Zeinali
Journal:  Avicenna J Med Biotechnol       Date:  2013-04

2.  The p40 subunit of interleukin (IL)-12 promotes stabilization and export of the p35 subunit: implications for improved IL-12 cytokine production.

Authors:  Rashmi Jalah; Margherita Rosati; Brunda Ganneru; Guy R Pilkington; Antonio Valentin; Viraj Kulkarni; Cristina Bergamaschi; Bhabadeb Chowdhury; Gen-Mu Zhang; Rachel Kelly Beach; Candido Alicea; Kate E Broderick; Niranjan Y Sardesai; George N Pavlakis; Barbara K Felber
Journal:  J Biol Chem       Date:  2013-01-07       Impact factor: 5.157

3.  Balancing the Expression and Production of a Heterodimeric Protein: Recombinant Agkisacutacin as a Novel Antithrombotic Drug Candidate.

Authors:  Yugang Guo; Jing Wu; Hao Jia; Wei Chen; Changsheng Shao; Lei Zhao; Jiajia Ma; Rui Li; Yongjun Zhong; Fang Fang; Dong Wang; Jie Sun; Fang Qian; Xiangrong Dai; Guohui Zhang; Zhigang Tian; Benjamin Xiaoyi Li; Weihua Xiao
Journal:  Sci Rep       Date:  2015-07-06       Impact factor: 4.379

4.  Comprehensive characterization of glutamine synthetase-mediated selection for the establishment of recombinant CHO cells producing monoclonal antibodies.

Authors:  Soo Min Noh; Seunghyeon Shin; Gyun Min Lee
Journal:  Sci Rep       Date:  2018-03-29       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.